Zobrazeno 1 - 10
of 459
pro vyhledávání: '"Svoboda Marek"'
Autor:
Svoboda Marek, Sana Jiri, Fabian Pavel, Kocakova Ilona, Gombosova Jana, Nekvindova Jana, Radova Lenka, Vyzula Rostislav, Slaby Ondrej
Publikováno v:
Radiation Oncology, Vol 7, Iss 1, p 195 (2012)
Abstract Background Rectal cancer accounts for approximately one third of all colorectal cancers (CRC), which belong among leading causes of cancer deaths worldwide. Standard treatment for locally advanced rectal cancer (cT3/4 and/or cN+) includes ne
Externí odkaz:
https://doaj.org/article/13c90bdd8a31401aa3838269ff394de2
Autor:
Hezova Renata, Bienertova-Vasku Julie, Sachlova Milana, Brezkova Veronika, Vasku Anna, Svoboda Marek, Radová Lenka, Kiss Igor, Vyzula Rostislav, Slaby Ondrej
Publikováno v:
European Journal of Medical Research, Vol 17, Iss 1, p 17 (2012)
Abstract Background Central Europe presents with the highest incidence of sporadic colorectal cancer (CRC) worldwide. As sporadic CRC represents a typical multifactorial disease, it is characterized by intense interaction of the genetic background wi
Externí odkaz:
https://doaj.org/article/a9ed6d7b7f594a8298ea34209008093e
Publikováno v:
Journal of Translational Medicine, Vol 10, Iss 1, p 103 (2012)
Abstract For the many years, the central dogma of molecular biology has been that RNA functions mainly as an informational intermediate between a DNA sequence and its encoded protein. But one of the great surprises of modern biology was the discovery
Externí odkaz:
https://doaj.org/article/fbc425e95d164641a5f82ba334fdd96f
Autor:
Redova Martina, Poprach Alexandr, Nekvindova Jana, Iliev Robert, Radova Lenka, Lakomy Radek, Svoboda Marek, Vyzula Rostislav, Slaby Ondrej
Publikováno v:
Journal of Translational Medicine, Vol 10, Iss 1, p 55 (2012)
Abstract Background There is no standard serum biomarker used for diagnosis or early detection of recurrence for renal cell carcinoma (RCC) patients. MicroRNAs (miRNAs) are abundant and highly stable in blood serum, and have been recently described a
Externí odkaz:
https://doaj.org/article/f50ee6d42f934d4bad16c06836813277
Autor:
Svoboda Marek, Sana Jiri, Redova Martina, Navratil Jiri, Palacova Marketa, Fabian Pavel, Slaby Ondrej, Vyzula Rostislav
Publikováno v:
Diagnostic Pathology, Vol 7, Iss 1, p 31 (2012)
Abstract Background Breast cancer is the most common malignancy with the highest incidence rates among women worldwide. Triple-negative breast cancer (TNBC) represents the major phenotype of basal-like molecular subtype of breast cancer, characterize
Externí odkaz:
https://doaj.org/article/d921ebb326924991a8ea50db557f72ce
Autor:
Kren Leos, Fabian Pavel, Poprach Alexandr, Svoboda Marek, Lakomy Radek, Jancovicova Jana, Slaby Ondrej, Michalek Jaroslav, Vyzula Rostislav
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 29, Iss 1, p 105 (2010)
Externí odkaz:
https://doaj.org/article/81e3cfdac6004e6aa4c5e81c1a484364
Autor:
Slaby Ondrej, Jancovicova Jana, Lakomy Radek, Svoboda Marek, Poprach Alexandr, Fabian Pavel, Kren Leos, Michalek Jaroslav, Vyzula Rostislav
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 29, Iss 1, p 90 (2010)
Abstract Background MicroRNAs are endogenously expressed regulatory noncoding RNAs. Previous studies have shown altered expression levels of several microRNAs in renal cell carcinoma. Methods We examined the expression levels of selected microRNAs in
Externí odkaz:
https://doaj.org/article/0a642d9479884796aa0d77e30417924c
Publikováno v:
Molecular Cancer, Vol 8, Iss 1, p 102 (2009)
Abstract MicroRNAs (miRNAs) are small non-coding RNAs 18-25 nucleotides in length that downregulate gene expression during various crucial cell processes such as apoptosis, differentiation and development. Changes in the expression profiles of miRNAs
Externí odkaz:
https://doaj.org/article/d6fd1e2d796448038dec08c9ba4119b6